Sinovac Biotech (SVA) Guides Q4, FY10 Well Below the Street
Tweet Send to a Friend
Sinovac Biotech Ltd. (Nasdaq: SVA) expects fourth quarter sales of approximately $7.8 million to $10.8 million ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
